agilon health, inc. (AGL) FY2026 Q2 Balance Sheet

agilon health, inc. (AGL) FY2026 Q2 Balance Sheet

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

Assets

1,591,336,000 US dollars

Current assets

1,418,534,000 US dollars

Non-current assets

172,802,000 US dollars

Liabilities

1,363,809,000 US dollars

Current liabilities

1,312,349,000 US dollars

Non-current liabilities

51,460,000 US dollars

Equity

227,527,000 US dollars

Receivables, net

1,059,786,000 US dollars

Cash and cash equivalents

107,184,000 US dollars

Prepaid expenses and other current assets, net

101,494,000 US dollars

Marketable securities

78,443,000 US dollars

Restricted cash and equivalents

71,627,000 US dollars

Other assets

88,157,000 US dollars

Intangible assets, net

60,132,000 US dollars

Property, equipment, and capitalized software, net

24,513,000 US dollars

Medical claims and related payables

1,022,506,000 US dollars

Accounts payable and accrued expenses

274,928,000 US dollars

Current debt

14,915,000 US dollars

Other liabilities

36,083,000 US dollars

Long-term debt

15,377,000 US dollars

Additional paid-in capital

2,138,657,000 US dollars

Common stock, $0.01 par value: 2,000,000 shares authorized; 16,785 and 16,589 shares issued and outstanding, respectively

168,000 US dollars

Accumulated other comprehensive income (loss)

154,000 US dollars

Accumulated deficit

negative 1,911,452,000 US dollars

Gross equity (calculated)

2,138,979,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

Chart connections

• Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
• Treasury shares and other negative equity contributions reduce equity.